AU2007287006B2 - System for abating neural stimulation side effects - Google Patents
System for abating neural stimulation side effects Download PDFInfo
- Publication number
- AU2007287006B2 AU2007287006B2 AU2007287006A AU2007287006A AU2007287006B2 AU 2007287006 B2 AU2007287006 B2 AU 2007287006B2 AU 2007287006 A AU2007287006 A AU 2007287006A AU 2007287006 A AU2007287006 A AU 2007287006A AU 2007287006 B2 AU2007287006 B2 AU 2007287006B2
- Authority
- AU
- Australia
- Prior art keywords
- neural stimulation
- side effect
- stimulation therapy
- therapy
- neural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000000638 stimulation Effects 0.000 title claims abstract description 309
- 230000001537 neural effect Effects 0.000 title claims abstract description 276
- 230000000694 effects Effects 0.000 title claims abstract description 151
- 238000002560 therapeutic procedure Methods 0.000 claims abstract description 196
- 206010011224 Cough Diseases 0.000 claims abstract description 48
- 230000002051 biphasic effect Effects 0.000 claims abstract description 48
- 238000000034 method Methods 0.000 claims abstract description 45
- 230000000747 cardiac effect Effects 0.000 claims description 46
- 230000004044 response Effects 0.000 claims description 15
- 230000000241 respiratory effect Effects 0.000 claims description 8
- 230000001225 therapeutic effect Effects 0.000 claims description 8
- 238000013479 data entry Methods 0.000 claims description 3
- 230000001360 synchronised effect Effects 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 22
- 210000005036 nerve Anatomy 0.000 description 38
- 210000002216 heart Anatomy 0.000 description 32
- 210000001186 vagus nerve Anatomy 0.000 description 22
- 206010019280 Heart failures Diseases 0.000 description 21
- 206010020772 Hypertension Diseases 0.000 description 20
- 230000002889 sympathetic effect Effects 0.000 description 20
- 230000001965 increasing effect Effects 0.000 description 17
- 230000002861 ventricular Effects 0.000 description 15
- 208000001871 Tachycardia Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 208000010125 myocardial infarction Diseases 0.000 description 14
- 108091008698 baroreceptors Proteins 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 12
- 238000007726 management method Methods 0.000 description 12
- 210000001774 pressoreceptor Anatomy 0.000 description 12
- 238000004891 communication Methods 0.000 description 11
- 238000001514 detection method Methods 0.000 description 11
- 230000002107 myocardial effect Effects 0.000 description 11
- 210000004165 myocardium Anatomy 0.000 description 11
- 208000033774 Ventricular Remodeling Diseases 0.000 description 10
- 230000035581 baroreflex Effects 0.000 description 10
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 10
- 230000003750 conditioning effect Effects 0.000 description 10
- 230000008602 contraction Effects 0.000 description 10
- 230000035479 physiological effects, processes and functions Effects 0.000 description 10
- 230000004936 stimulating effect Effects 0.000 description 10
- 210000002820 sympathetic nervous system Anatomy 0.000 description 10
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 9
- 238000007634 remodeling Methods 0.000 description 9
- 230000001746 atrial effect Effects 0.000 description 8
- 230000008035 nerve activity Effects 0.000 description 8
- 230000033764 rhythmic process Effects 0.000 description 8
- 230000003247 decreasing effect Effects 0.000 description 7
- 230000001734 parasympathetic effect Effects 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 230000036316 preload Effects 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 230000035939 shock Effects 0.000 description 7
- 230000036471 bradycardia Effects 0.000 description 6
- 208000006218 bradycardia Diseases 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000029058 respiratory gaseous exchange Effects 0.000 description 6
- 238000004448 titration Methods 0.000 description 6
- 238000002604 ultrasonography Methods 0.000 description 6
- 206010020880 Hypertrophy Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000002837 heart atrium Anatomy 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000011514 reflex Effects 0.000 description 5
- 230000006794 tachycardia Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000001515 vagal effect Effects 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000002567 autonomic effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 206010015037 epilepsy Diseases 0.000 description 4
- 210000004731 jugular vein Anatomy 0.000 description 4
- 208000031225 myocardial ischemia Diseases 0.000 description 4
- 230000007383 nerve stimulation Effects 0.000 description 4
- 210000000653 nervous system Anatomy 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000001960 triggered effect Effects 0.000 description 4
- 208000030814 Eating disease Diseases 0.000 description 3
- 208000019454 Feeding and Eating disease Diseases 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 3
- 208000016285 Movement disease Diseases 0.000 description 3
- 206010049447 Tachyarrhythmia Diseases 0.000 description 3
- 230000003206 anti-remodeling effect Effects 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 238000013528 artificial neural network Methods 0.000 description 3
- 238000013194 cardioversion Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 235000014632 disordered eating Nutrition 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 230000004217 heart function Effects 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 210000002569 neuron Anatomy 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 230000002459 sustained effect Effects 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 208000018672 Dilatation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000009612 Laryngismus Diseases 0.000 description 2
- 206010023891 Laryngospasm Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 210000003192 autonomic ganglia Anatomy 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 210000005242 cardiac chamber Anatomy 0.000 description 2
- 210000001326 carotid sinus Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 208000035850 clinical syndrome Diseases 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002964 excitative effect Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 230000003843 mucus production Effects 0.000 description 2
- 210000001087 myotubule Anatomy 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000008701 parasympathetic activation Effects 0.000 description 2
- 230000036513 peripheral conductance Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000037081 physical activity Effects 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 210000001747 pupil Anatomy 0.000 description 2
- 238000000718 qrs complex Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 210000001044 sensory neuron Anatomy 0.000 description 2
- 230000000392 somatic effect Effects 0.000 description 2
- 210000005070 sphincter Anatomy 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 206010047302 ventricular tachycardia Diseases 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010003130 Arrhythmia supraventricular Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010052337 Diastolic dysfunction Diseases 0.000 description 1
- 241001632160 Dismorphiinae Species 0.000 description 1
- 208000002251 Dissecting Aneurysm Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010060820 Joint injury Diseases 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 206010024119 Left ventricular failure Diseases 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 208000014139 Retinal vascular disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241000287181 Sturnus vulgaris Species 0.000 description 1
- 206010071436 Systolic dysfunction Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 208000009982 Ventricular Dysfunction Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 238000003782 apoptosis assay Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 229940030602 cardiac therapy drug Drugs 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000297 inotrophic effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000012804 iterative process Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002644 neurohormonal effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000005037 parasympathetic nerve Anatomy 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 210000004345 peroneal nerve Anatomy 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005522 programmed cell death Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009158 reflex pathway Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000002633 shock therapy Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 230000009943 skeletal muscle blood flow Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000001321 subclavian vein Anatomy 0.000 description 1
- 230000008700 sympathetic activation Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000006815 ventricular dysfunction Effects 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/36128—Control systems
- A61N1/36132—Control systems using patient feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02028—Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4041—Evaluating nerves condition
- A61B5/4047—Evaluating nerves condition afferent nerves, i.e. nerves that relay impulses to the central nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4029—Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
- A61B5/4035—Evaluating the autonomic nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3601—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Electrotherapy Devices (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2012200979A AU2012200979B2 (en) | 2006-08-25 | 2012-02-20 | System for abating neural stimulation side effects |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/467,264 | 2006-08-25 | ||
| US11/467,264 US8103341B2 (en) | 2006-08-25 | 2006-08-25 | System for abating neural stimulation side effects |
| PCT/US2007/072444 WO2008024557A1 (en) | 2006-08-25 | 2007-06-29 | System for abating neural stimulation side effects |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012200979A Division AU2012200979B2 (en) | 2006-08-25 | 2012-02-20 | System for abating neural stimulation side effects |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007287006A1 AU2007287006A1 (en) | 2008-02-28 |
| AU2007287006B2 true AU2007287006B2 (en) | 2011-11-24 |
Family
ID=38707284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007287006A Ceased AU2007287006B2 (en) | 2006-08-25 | 2007-06-29 | System for abating neural stimulation side effects |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8103341B2 (enExample) |
| EP (2) | EP2902076A1 (enExample) |
| JP (1) | JP2010501269A (enExample) |
| CN (2) | CN101505827B (enExample) |
| AU (1) | AU2007287006B2 (enExample) |
| WO (1) | WO2008024557A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8897881B2 (en) | 2006-08-25 | 2014-11-25 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
Families Citing this family (172)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100810989B1 (ko) * | 2000-04-17 | 2008-03-11 | 바이보메트릭스, 인크. | 생리학 신호의 보행 모니터링을 위한 시스템 및 방법 |
| US20080082018A1 (en) * | 2003-04-10 | 2008-04-03 | Sackner Marvin A | Systems and methods for respiratory event detection |
| US7727161B2 (en) * | 2003-04-10 | 2010-06-01 | Vivometrics, Inc. | Systems and methods for monitoring cough |
| US20040226556A1 (en) | 2003-05-13 | 2004-11-18 | Deem Mark E. | Apparatus for treating asthma using neurotoxin |
| US9492084B2 (en) | 2004-06-18 | 2016-11-15 | Adidas Ag | Systems and methods for monitoring subjects in potential physiological distress |
| US9504410B2 (en) * | 2005-09-21 | 2016-11-29 | Adidas Ag | Band-like garment for physiological monitoring |
| JP2008538520A (ja) * | 2005-04-20 | 2008-10-30 | ヴィーヴォメトリックス インコーポレイテッド | ヒト以外の動物の非侵襲的生理学的モニタシステム及び方法 |
| CA2606699C (en) | 2005-05-20 | 2017-04-18 | Vivometrics, Inc. | Methods and systems for determining dynamic hyperinflation |
| US12433837B2 (en) | 2005-07-22 | 2025-10-07 | The Foundry, Llc | Systems and methods for delivery of a therapeutic agent |
| WO2007014003A2 (en) | 2005-07-22 | 2007-02-01 | The Foundry Inc. | Systems and methods for delivery of a therapeutic agent |
| US8033996B2 (en) | 2005-07-26 | 2011-10-11 | Adidas Ag | Computer interfaces including physiologically guided avatars |
| US8762733B2 (en) * | 2006-01-30 | 2014-06-24 | Adidas Ag | System and method for identity confirmation using physiologic biometrics to determine a physiologic fingerprint |
| US20070270671A1 (en) * | 2006-04-10 | 2007-11-22 | Vivometrics, Inc. | Physiological signal processing devices and associated processing methods |
| US8475387B2 (en) * | 2006-06-20 | 2013-07-02 | Adidas Ag | Automatic and ambulatory monitoring of congestive heart failure patients |
| US9352161B2 (en) | 2006-10-26 | 2016-05-31 | Boston Scientific Neuromodulation Corporation | Method of maintaining intensity output while adjusting pulse width or amplitude |
| US9833184B2 (en) * | 2006-10-27 | 2017-12-05 | Adidas Ag | Identification of emotional states using physiological responses |
| US20080167696A1 (en) * | 2006-12-28 | 2008-07-10 | Cvrx, Inc. | Stimulus waveforms for baroreflex activation |
| WO2008092246A1 (en) * | 2007-01-29 | 2008-08-07 | Simon Fraser University | Transvascular nerve stimulation apparatus and methods |
| US20080320029A1 (en) * | 2007-02-16 | 2008-12-25 | Stivoric John M | Lifeotype interfaces |
| US8224453B2 (en) | 2007-03-15 | 2012-07-17 | Advanced Neuromodulation Systems, Inc. | Spinal cord stimulation to treat pain |
| US8406877B2 (en) * | 2007-03-19 | 2013-03-26 | Cardiac Pacemakers, Inc. | Selective nerve stimulation with optionally closed-loop capabilities |
| US20080262557A1 (en) * | 2007-04-19 | 2008-10-23 | Brown Stephen J | Obesity management system |
| US8781595B2 (en) | 2007-04-30 | 2014-07-15 | Medtronic, Inc. | Chopper mixer telemetry circuit |
| ES2602989T3 (es) | 2007-07-20 | 2017-02-23 | Boston Scientific Neuromodulation Corporation | Sistema de estimulación para controlar el orden de reclutamiento neuronal y el efecto clínico |
| US11376435B2 (en) * | 2007-07-20 | 2022-07-05 | Boston Scientific Neuromodulation Corporation | System and method for shaped phased current delivery |
| US20130304152A1 (en) * | 2012-05-14 | 2013-11-14 | Boston Scientific Neuromodulation Corporation | System and method for shaped phased current delivery |
| US8380314B2 (en) | 2007-09-26 | 2013-02-19 | Medtronic, Inc. | Patient directed therapy control |
| US7848816B1 (en) | 2007-12-27 | 2010-12-07 | Pacesetter, Inc. | Acquiring nerve activity from carotid body and/or sinus |
| US7949398B1 (en) * | 2007-12-27 | 2011-05-24 | Pacesetter, Inc. | Acquiring nerve activity from carotid body and/or sinus |
| EP2249908B1 (en) | 2008-01-25 | 2014-01-01 | Medtronic, Inc. | Sleep stage detection |
| US11305121B2 (en) * | 2013-03-15 | 2022-04-19 | Flint Hills Scientific, Llc. | Programmable autotitrating of electrical parameters of implantable medical device |
| US8483831B1 (en) * | 2008-02-15 | 2013-07-09 | Holaira, Inc. | System and method for bronchial dilation |
| US8805518B2 (en) * | 2008-05-09 | 2014-08-12 | Medtronic, Inc. | Peripheral nerve field stimulation control |
| WO2009137819A1 (en) | 2008-05-09 | 2009-11-12 | Innovative Pulmonary Solutions, Inc. | Systems, assemblies, and methods for treating a bronchial tree |
| AU2012261486B2 (en) * | 2008-07-08 | 2014-02-27 | Cardiac Pacemakers, Inc. | Systems for delivering vagal nerve stimulation |
| WO2010005482A1 (en) | 2008-07-08 | 2010-01-14 | Cardiac Pacemakers, Inc. | Systems for delivering vagal nerve stimulation |
| US20100042185A1 (en) * | 2008-08-12 | 2010-02-18 | Curtis Guy P | System and method for transvascular activation of cardiac nerves to improve heart function |
| US8463376B2 (en) | 2008-08-12 | 2013-06-11 | Guy P. Curtis | System and method for transvascular activation of cardiac nerves with automatic restart |
| US8457747B2 (en) | 2008-10-20 | 2013-06-04 | Cyberonics, Inc. | Neurostimulation with signal duration determined by a cardiac cycle |
| US8249708B2 (en) * | 2008-10-31 | 2012-08-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8386053B2 (en) * | 2008-10-31 | 2013-02-26 | Medtronic, Inc. | Subclavian ansae stimulation |
| US8005539B2 (en) * | 2008-10-31 | 2011-08-23 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US9775987B2 (en) * | 2008-10-31 | 2017-10-03 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8611996B2 (en) * | 2008-10-31 | 2013-12-17 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8452394B2 (en) * | 2008-10-31 | 2013-05-28 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8774918B2 (en) * | 2008-10-31 | 2014-07-08 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8532779B2 (en) * | 2008-10-31 | 2013-09-10 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8688210B2 (en) * | 2008-10-31 | 2014-04-01 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8260412B2 (en) * | 2008-10-31 | 2012-09-04 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US9597505B2 (en) * | 2008-10-31 | 2017-03-21 | Medtronic, Inc. | Implantable medical device crosstalk evaluation and mitigation |
| US8255057B2 (en) | 2009-01-29 | 2012-08-28 | Nevro Corporation | Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions |
| US8548593B2 (en) * | 2008-11-10 | 2013-10-01 | Cardiac Pacemakers, Inc. | Distal end converter for a medical device lead |
| US20150105840A1 (en) | 2008-12-05 | 2015-04-16 | Spr Therapeutics, Llc | Systems and methods to place one or more leads in tissue for providing functional and/or therapeutic stimulation |
| WO2010088539A1 (en) | 2009-01-30 | 2010-08-05 | Medtronic, Inc. | Detecting and treating electromechanical dissociation of the heart |
| EP3228350B1 (en) | 2009-04-22 | 2025-09-24 | Nevro Corporation | Device for selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods |
| CA2758944C (en) | 2009-04-22 | 2023-03-14 | Konstantinos Alataris | Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods |
| AU2010254490B2 (en) * | 2009-05-26 | 2014-06-12 | Cardiac Pacemakers, Inc. | Helically formed coil for a neural cuff electrode |
| AU2010273546B2 (en) * | 2009-07-15 | 2013-08-29 | Cardiac Pacemakers, Inc. | Physiological vibration detection in an implanted medical device |
| US8285373B2 (en) * | 2009-07-15 | 2012-10-09 | Cardiac Pacemakers, Inc. | Remote sensing in an implantable medical device |
| JP5613234B2 (ja) | 2009-07-15 | 2014-10-22 | カーディアック ペースメイカーズ， インコーポレイテッド | 埋め込み型医療装置における遠隔ペース検出 |
| US9649153B2 (en) | 2009-10-27 | 2017-05-16 | Holaira, Inc. | Delivery devices with coolable energy emitting assemblies |
| US9770204B2 (en) * | 2009-11-11 | 2017-09-26 | Medtronic, Inc. | Deep brain stimulation for sleep and movement disorders |
| US20130178765A1 (en) * | 2011-11-29 | 2013-07-11 | David J. Mishelevich | Ultrasound neuromodulation of spinal cord |
| US20120226091A1 (en) * | 2011-03-06 | 2012-09-06 | Mishelevich David J | Ultrasound neuromodulation treatment of pain |
| CA2780608C (en) | 2009-11-11 | 2019-02-26 | Innovative Pulmonary Solutions, Inc. | Systems, apparatuses, and methods for treating tissue and controlling stenosis |
| US8911439B2 (en) | 2009-11-11 | 2014-12-16 | Holaira, Inc. | Non-invasive and minimally invasive denervation methods and systems for performing the same |
| JP5624672B2 (ja) | 2010-04-15 | 2014-11-12 | カーディアック ペースメイカーズ， インコーポレイテッド | 断続的神経刺激による過渡反応を使用する自律神経調節 |
| EP2575959B1 (en) * | 2010-06-03 | 2017-07-12 | Cardiac Pacemakers, Inc. | System for controlling target of neurostimulation using temporal parameters |
| EP2575961B1 (en) | 2010-06-03 | 2018-08-29 | Cardiac Pacemakers, Inc. | System for spatially selective vagus nerve stimulation |
| EP2582429B1 (en) | 2010-06-18 | 2016-01-13 | Cardiac Pacemakers, Inc. | Neurostimulation system with control using evoked responses |
| US9211411B2 (en) | 2010-08-26 | 2015-12-15 | Medtronic, Inc. | Therapy for rapid eye movement behavior disorder (RBD) |
| EP3002037B1 (en) | 2010-09-15 | 2018-06-06 | Cardiac Pacemakers, Inc. | Automatic selection of lead configuration for a neural stimulation lead |
| US8788047B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
| US8788048B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
| US8788046B2 (en) | 2010-11-11 | 2014-07-22 | Spr Therapeutics, Llc | Systems and methods for the treatment of pain through neural fiber stimulation |
| EP2658601A1 (en) * | 2010-12-29 | 2013-11-06 | Cardiac Pacemakers, Inc. | Neuro cardiac therapy using sensed pressure |
| JP5806334B2 (ja) * | 2010-12-29 | 2015-11-10 | カーディアック ペースメイカーズ， インコーポレイテッド | 電気インピーダンスを用いた心臓神経治療 |
| WO2012148845A1 (en) * | 2011-04-25 | 2012-11-01 | Cardiac Pacemakers, Inc. | Systems to account for neck movement during nerve stimulation |
| US20120296387A1 (en) | 2011-05-19 | 2012-11-22 | Xusheng Zhang | Phrenic nerve stimulation detection using heart sounds |
| US8617082B2 (en) | 2011-05-19 | 2013-12-31 | Medtronic, Inc. | Heart sounds-based pacing optimization |
| US8777874B2 (en) * | 2011-05-24 | 2014-07-15 | Medtronic, Inc. | Acoustic based cough detection |
| US9026214B2 (en) | 2011-06-23 | 2015-05-05 | Cardiac Pacemakers, Inc. | Systems and methods for avoiding aspiration during autonomic modulation therapy |
| EP2726142B1 (en) | 2011-06-28 | 2017-05-10 | Cardiac Pacemakers, Inc. | Strain relief feature for an implantable medical device lead |
| WO2013006295A1 (en) | 2011-07-07 | 2013-01-10 | Cardiac Pacemakers, Inc. | Insulation and stability features for an implantable medical device lead |
| WO2013036880A1 (en) | 2011-09-08 | 2013-03-14 | Thacker James R | Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods |
| US8700150B2 (en) | 2012-01-17 | 2014-04-15 | Cyberonics, Inc. | Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration |
| US8886311B2 (en) | 2012-01-27 | 2014-11-11 | Medtronic, Inc. | Techniques for mitigating motion artifacts from implantable physiological sensors |
| JP2013165768A (ja) * | 2012-02-14 | 2013-08-29 | Olympus Corp | 神経刺激装置およびその制御方法 |
| US9855431B2 (en) | 2012-03-19 | 2018-01-02 | Cardiac Pacemakers, Inc. | Systems and methods for monitoring for nerve damage |
| WO2013142053A1 (en) | 2012-03-21 | 2013-09-26 | Cardiac Pacemakers, Inc. | Systems and methods for stimulation of vagus nerve |
| US9403007B2 (en) | 2012-06-14 | 2016-08-02 | Cardiac Pacemakers, Inc. | Systems and methods to reduce syncope risk during neural stimulation therapy |
| US8688212B2 (en) | 2012-07-20 | 2014-04-01 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation |
| JP6162245B2 (ja) | 2012-10-02 | 2017-07-12 | カーディアック ペースメイカーズ， インコーポレイテッド | カフ電極アセンブリを備えるリードアセンブリ |
| EP2903686B1 (en) | 2012-10-02 | 2018-10-24 | Cardiac Pacemakers, Inc. | Pinch to open cuff electrode |
| CN103785105B (zh) * | 2012-10-30 | 2016-08-17 | 苏州景昱医疗器械有限公司 | 一种病人控制器、植入式神经刺激系统及反馈调节方法 |
| US8923964B2 (en) * | 2012-11-09 | 2014-12-30 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation |
| US9452290B2 (en) | 2012-11-09 | 2016-09-27 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation |
| US9643008B2 (en) | 2012-11-09 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation |
| US9398933B2 (en) | 2012-12-27 | 2016-07-26 | Holaira, Inc. | Methods for improving drug efficacy including a combination of drug administration and nerve modulation |
| CN104884124B (zh) | 2012-12-28 | 2016-11-16 | 心脏起搏器股份公司 | 刺激封套与植入工具 |
| EP2945691B1 (en) | 2013-01-21 | 2019-03-06 | Cala Health, Inc. | Devices for controlling tremor |
| US12453853B2 (en) | 2013-01-21 | 2025-10-28 | Cala Health, Inc. | Multi-modal stimulation for treating tremor |
| US9295840B1 (en) | 2013-01-22 | 2016-03-29 | Nevro Corporation | Systems and methods for automatically programming patient therapy devices |
| US9731133B1 (en) | 2013-01-22 | 2017-08-15 | Nevro Corp. | Systems and methods for systematically testing a plurality of therapy programs in patient therapy devices |
| US9895538B1 (en) | 2013-01-22 | 2018-02-20 | Nevro Corp. | Systems and methods for deploying patient therapy devices |
| EP2956208B1 (en) | 2013-02-13 | 2021-01-13 | Cardiac Pacemakers, Inc. | Cuff electrode with integrated tendril |
| US20140249378A1 (en) * | 2013-03-02 | 2014-09-04 | Isonea Limited | Systems, methods and kits for measuring cough and respiratory rate using an accelerometer |
| US9643011B2 (en) | 2013-03-14 | 2017-05-09 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation |
| US20140277267A1 (en) | 2013-03-15 | 2014-09-18 | Boston Scientific Neuromodulation Corporation | Neuromodulation system and method for transitioning between programming modes |
| US9440076B2 (en) * | 2013-03-15 | 2016-09-13 | Globus Medical, Inc. | Spinal cord stimulator system |
| US9895539B1 (en) | 2013-06-10 | 2018-02-20 | Nevro Corp. | Methods and systems for disease treatment using electrical stimulation |
| EP3777963B1 (en) * | 2013-07-19 | 2023-08-30 | MED-EL Elektromedizinische Geräte GmbH | Triphasic pulses to reduce undesirable side-effects in cochlear implants |
| US9999773B2 (en) | 2013-10-30 | 2018-06-19 | Cyberonics, Inc. | Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters |
| US20150126822A1 (en) * | 2013-11-01 | 2015-05-07 | Medtronic Monitoring, Inc. | Congestive heart failure risk status determination methods and related devices |
| US10149978B1 (en) | 2013-11-07 | 2018-12-11 | Nevro Corp. | Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods |
| US9511228B2 (en) | 2014-01-14 | 2016-12-06 | Cyberonics, Inc. | Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation |
| US9713719B2 (en) | 2014-04-17 | 2017-07-25 | Cyberonics, Inc. | Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction |
| US9409024B2 (en) | 2014-03-25 | 2016-08-09 | Cyberonics, Inc. | Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction |
| US9950169B2 (en) | 2014-04-25 | 2018-04-24 | Cyberonics, Inc. | Dynamic stimulation adjustment for identification of a neural fulcrum |
| US9272143B2 (en) | 2014-05-07 | 2016-03-01 | Cyberonics, Inc. | Responsive neurostimulation for the treatment of chronic cardiac dysfunction |
| US9415224B2 (en) | 2014-04-25 | 2016-08-16 | Cyberonics, Inc. | Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction |
| AU2015271774B2 (en) | 2014-06-02 | 2020-04-16 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor |
| US9533153B2 (en) | 2014-08-12 | 2017-01-03 | Cyberonics, Inc. | Neurostimulation titration process |
| US9770599B2 (en) | 2014-08-12 | 2017-09-26 | Cyberonics, Inc. | Vagus nerve stimulation and subcutaneous defibrillation system |
| US9737716B2 (en) | 2014-08-12 | 2017-08-22 | Cyberonics, Inc. | Vagus nerve and carotid baroreceptor stimulation system |
| US9924904B2 (en) | 2014-09-02 | 2018-03-27 | Medtronic, Inc. | Power-efficient chopper amplifier |
| EP3206745A1 (en) | 2014-10-13 | 2017-08-23 | Cardiac Pacemakers, Inc. | Systems and methods for delivering vagal therapy |
| EP4085970A1 (en) | 2014-11-03 | 2022-11-09 | Presidio Medical, Inc. | Neuromodulation device |
| US9504832B2 (en) | 2014-11-12 | 2016-11-29 | Cyberonics, Inc. | Neurostimulation titration process via adaptive parametric modification |
| US9895543B2 (en) * | 2014-12-22 | 2018-02-20 | Biotronik Se & Co. Kg | Implantable pulse generator system for vagal nerve stimulation |
| CN107249681A (zh) * | 2015-02-04 | 2017-10-13 | 波士顿科学神经调制公司 | 在神经刺激波形中对电荷恢复编程的方法和装置 |
| US9517344B1 (en) | 2015-03-13 | 2016-12-13 | Nevro Corporation | Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator |
| CA2995215A1 (en) * | 2015-04-21 | 2016-10-27 | The Regents Of The University Of California | System and method for monitoring and treating arrhythmia and cardiac function via the intrinsic cardiac nervous system |
| EP4342516A3 (en) | 2015-06-10 | 2024-07-10 | Cala Health, Inc. | Systems and methods for peripheral nerve stimulation to treat tremor with detachable therapy and monitoring units |
| EP3111990B1 (fr) | 2015-06-29 | 2019-02-27 | Sorin CRM SAS | Système de traitement par stimulation, notamment de stimulation du nerf vague, par mise en oeuvre d'un modèle de transition d'état avec apprentissage préalable |
| EP3113033B1 (fr) | 2015-06-29 | 2019-01-09 | Sorin CRM SAS | Système de traitement par stimulation, notamment du nerf vague, par mise en oeuvre d'un modèle de transition d'états |
| EP3111991B1 (fr) | 2015-06-29 | 2020-01-29 | Sorin CRM SAS | Système de traitement par stimulation, notamment de stimulation du nerf vague, par mise en oeuvre d'un modèle de transition d'états autoadaptable en fonction des niveaux physiques ou physiologiques |
| EP3111992B1 (fr) | 2015-06-29 | 2018-08-01 | Sorin CRM SAS | Système de traitement par stimulation, notamment de stimulation du nerf vague, par mise en oeuvre d'un modèle de transition d'état opérant à des résolutions temporelles ou spatiales multiples |
| US20170007497A1 (en) * | 2015-07-08 | 2017-01-12 | James Madison Innovations, Inc. | Vibratory Cough Suppression |
| CN108135519B (zh) * | 2015-08-18 | 2022-08-09 | 路易斯维尔大学研究基金会公司 | 同步脉冲检测器 |
| US10300282B2 (en) | 2015-09-18 | 2019-05-28 | Medtronic, Inc. | Electrical stimulation therapy for inducing patient sensations |
| US10675468B2 (en) * | 2015-09-18 | 2020-06-09 | Medtronic, Inc. | Electrical stimulation therapy for inducing patient sensations |
| CN108348746B (zh) | 2015-09-23 | 2021-10-12 | 卡拉健康公司 | 用于手指或手中的周围神经刺激以治疗手震颤的系统和方法 |
| WO2017062379A1 (en) | 2015-10-05 | 2017-04-13 | Cyberonics, Inc. | Stimulation suspension in response to patient discomfort or state |
| US10300277B1 (en) | 2015-12-14 | 2019-05-28 | Nevro Corp. | Variable amplitude signals for neurological therapy, and associated systems and methods |
| CN108778411B (zh) | 2016-01-21 | 2022-06-03 | 卡拉健康公司 | 用来治疗与膀胱过动症相关的疾病的用于外周神经调制的系统、方法和装置 |
| EP3423146A4 (en) * | 2016-02-29 | 2019-12-04 | Galvani Bioelectronics Limited | NEUROMODULATION DEVICE |
| CA3015372A1 (en) * | 2016-03-09 | 2017-09-14 | CARDIONOMIC, Inc. | Cardiac contractility neurostimulation systems and methods |
| DE102016104913B4 (de) * | 2016-03-16 | 2018-04-26 | Forschungszentrum Jülich GmbH | Vorrichtung zur effektiven, invasiven und amplitudenmodulierten Neurostimulation |
| US20190070411A1 (en) * | 2016-03-18 | 2019-03-07 | Sorin Crm Sas | Active implantable medical device for combined treatment of cardiac rhythm and of respiratory rhythm |
| US10124170B2 (en) | 2016-06-13 | 2018-11-13 | Cyberonics, Inc. | Neurostimulator with titration assist |
| CA3030029A1 (en) | 2016-07-08 | 2018-01-11 | Cala Health, Inc. | Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes |
| US10780274B2 (en) | 2016-08-22 | 2020-09-22 | Boston Scientific Neuromodulation Corporation | Systems and methods for delivering spinal cord stimulation therapy |
| IL264904B2 (en) | 2016-08-25 | 2025-05-01 | Cala Health Inc | Systems and methods for treating cardiac dysfunction through peripheral nerve stimulation |
| US11540973B2 (en) | 2016-10-21 | 2023-01-03 | Spr Therapeutics, Llc | Method and system of mechanical nerve stimulation for pain relief |
| CN106821357B (zh) * | 2016-11-18 | 2019-05-31 | 温州芳植生物科技有限公司 | 一种针对肌强直、肌痉挛病人的防摔装置 |
| CN106512215B (zh) * | 2016-12-20 | 2023-05-05 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激疗法的参数输入方法 |
| CN106730334B (zh) * | 2016-12-20 | 2023-05-02 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激系统 |
| CN106730335A (zh) * | 2016-12-20 | 2017-05-31 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激疗法的参数输入方法及系统 |
| CN106621039A (zh) * | 2016-12-20 | 2017-05-10 | 北京品驰医疗设备有限公司 | 一种骶神经电刺激疗法的参数输入方法及系统 |
| CA3058786A1 (en) | 2017-04-03 | 2018-10-11 | Cala Health, Inc. | Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder |
| GB201709666D0 (en) * | 2017-06-16 | 2017-08-02 | Ucl Business Plc | Detecting activity in peripheral nerves |
| US12029591B2 (en) | 2017-06-20 | 2024-07-09 | Livanova Usa, Inc. | Titration assist management dashboard |
| US11167142B2 (en) * | 2017-09-14 | 2021-11-09 | Livanova Usa, Inc. | Customizable titration for an implantable neurostimulator |
| WO2019143790A1 (en) | 2018-01-17 | 2019-07-25 | Cala Health, Inc. | Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation |
| EP4252635A3 (en) * | 2018-07-16 | 2023-11-15 | Mayo Foundation for Medical Education and Research | Systems and methods for low-power encoding of continuous physiological signals in a remote physiological monitor |
| US11590352B2 (en) | 2019-01-29 | 2023-02-28 | Nevro Corp. | Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods |
| US12251560B1 (en) | 2019-08-13 | 2025-03-18 | Cala Health, Inc. | Connection quality determination for wearable neurostimulation systems |
| US11890468B1 (en) | 2019-10-03 | 2024-02-06 | Cala Health, Inc. | Neurostimulation systems with event pattern detection and classification |
| JP2025521829A (ja) | 2022-07-01 | 2025-07-10 | アルタ・パートナーズ・ベーフェー | 鎖骨下動脈の周囲の除神経のシステムおよび方法 |
| US12467932B2 (en) | 2022-10-24 | 2025-11-11 | West Virginia University Board of Governors on behalf of West Virginia University | Methods of improving neurodegenerative disorders by targeted delivery of therapeutic agents |
| CN115738077A (zh) * | 2022-11-04 | 2023-03-07 | 西安交通大学 | 一种迷走神经刺激上行传导阻滞装置及其控制方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040193231A1 (en) * | 2001-08-31 | 2004-09-30 | Biocontrol Medical Ltd. | Selective nerve fiber stimulation for treating heart conditions |
| US20060116737A1 (en) * | 2004-11-30 | 2006-06-01 | Cardiac Pacemakers, Inc. | Neural stimulation with avoidance of inappropriate stimulation |
| US20060190053A1 (en) * | 2002-03-22 | 2006-08-24 | Dobak John D Iii | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6141587A (en) * | 1996-08-19 | 2000-10-31 | Mower Family Chf Treatment Irrevocable Trust | Augmentation of muscle contractility by biphasic stimulation |
| US5205285A (en) * | 1991-06-14 | 1993-04-27 | Cyberonics, Inc. | Voice suppression of vagal stimulation |
| US5314454A (en) * | 1992-04-02 | 1994-05-24 | Jaeger Robert J | Method and apparatus of artifically stimulating cough reflex |
| US5330515A (en) * | 1992-06-17 | 1994-07-19 | Cyberonics, Inc. | Treatment of pain by vagal afferent stimulation |
| US6480743B1 (en) * | 2000-04-05 | 2002-11-12 | Neuropace, Inc. | System and method for adaptive brain stimulation |
| US6213960B1 (en) * | 1998-06-19 | 2001-04-10 | Revivant Corporation | Chest compression device with electro-stimulation |
| US7076307B2 (en) * | 2002-05-09 | 2006-07-11 | Boveja Birinder R | Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders |
| US6269270B1 (en) * | 1998-10-26 | 2001-07-31 | Birinder Bob Boveja | Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator |
| US6341236B1 (en) * | 1999-04-30 | 2002-01-22 | Ivan Osorio | Vagal nerve stimulation techniques for treatment of epileptic seizures |
| US7127290B2 (en) * | 1999-10-01 | 2006-10-24 | Cardiac Pacemakers, Inc. | Cardiac rhythm management systems and methods predicting congestive heart failure status |
| US7623926B2 (en) * | 2000-09-27 | 2009-11-24 | Cvrx, Inc. | Stimulus regimens for cardiovascular reflex control |
| US6775573B2 (en) * | 2001-03-01 | 2004-08-10 | Science Medicus Inc. | Electrical method to control autonomic nerve stimulation of gastrointestinal tract |
| US6684105B2 (en) * | 2001-08-31 | 2004-01-27 | Biocontrol Medical, Ltd. | Treatment of disorders by unidirectional nerve stimulation |
| US7974693B2 (en) * | 2001-08-31 | 2011-07-05 | Bio Control Medical (B.C.M.) Ltd. | Techniques for applying, configuring, and coordinating nerve fiber stimulation |
| US7050856B2 (en) * | 2002-01-11 | 2006-05-23 | Medtronic, Inc. | Variation of neural-stimulation parameters |
| US7142917B2 (en) * | 2002-12-04 | 2006-11-28 | Terumo Kabushiki Kaisha | Heart treatment equipment and method for preventing fatal arrhythmia |
| WO2004075982A1 (en) * | 2003-02-21 | 2004-09-10 | Medtronic, Inc. | Implantable neurostimulator programming with battery longevity indication |
| JP4252830B2 (ja) * | 2003-03-24 | 2009-04-08 | テルモ株式会社 | 心臓治療装置 |
| US7894908B2 (en) * | 2003-04-02 | 2011-02-22 | Medtronic, Inc. | Neurostimulation therapy optimization based on a rated session log |
| US7489970B2 (en) * | 2003-04-02 | 2009-02-10 | Medtronic, Inc. | Management of neurostimulation therapy using parameter sets |
| US7548786B2 (en) * | 2003-04-02 | 2009-06-16 | Medtronic, Inc. | Library for management of neurostimulation therapy programs |
| US7463928B2 (en) * | 2003-04-25 | 2008-12-09 | Medtronic, Inc. | Identifying combinations of electrodes for neurostimulation therapy |
| CA2534363A1 (en) * | 2003-08-01 | 2005-02-10 | Brad Fowler | Apparatus and methods for applying neural stimulation to a patient |
| EP1670547B1 (en) * | 2003-08-18 | 2008-11-12 | Cardiac Pacemakers, Inc. | Patient monitoring system |
| US7252090B2 (en) * | 2003-09-15 | 2007-08-07 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using neural network |
| US7184837B2 (en) * | 2003-09-15 | 2007-02-27 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using bayesian networks |
| US8396565B2 (en) * | 2003-09-15 | 2013-03-12 | Medtronic, Inc. | Automatic therapy adjustments |
| US7617002B2 (en) | 2003-09-15 | 2009-11-10 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using decision trees |
| US7239926B2 (en) * | 2003-09-15 | 2007-07-03 | Medtronic, Inc. | Selection of neurostimulator parameter configurations using genetic algorithms |
| US20050070970A1 (en) * | 2003-09-29 | 2005-03-31 | Knudson Mark B. | Movement disorder stimulation with neural block |
| US7206632B2 (en) * | 2003-10-02 | 2007-04-17 | Medtronic, Inc. | Patient sensory response evaluation for neuromodulation efficacy rating |
| US8467876B2 (en) * | 2003-10-15 | 2013-06-18 | Rmx, Llc | Breathing disorder detection and therapy delivery device and method |
| EP1786510A4 (en) * | 2004-07-15 | 2009-12-02 | Northstar Neuroscience Inc | SYSTEMS AND METHOD FOR INCREASING OR INFLUENCING THE EFFICIENCY OR EFFECTIVENESS OF NEURAL STIMULATION |
| US7819909B2 (en) * | 2004-07-20 | 2010-10-26 | Medtronic, Inc. | Therapy programming guidance based on stored programming history |
| WO2006044793A2 (en) * | 2004-10-18 | 2006-04-27 | Louisiana Tech University Foundation | Medical devices for the detection, prevention and/or treatment of neurological disorders, and methods related thereto |
| US7366571B2 (en) * | 2004-12-10 | 2008-04-29 | Cyberonics, Inc. | Neurostimulator with activation based on changes in body temperature |
| US8600521B2 (en) | 2005-01-27 | 2013-12-03 | Cyberonics, Inc. | Implantable medical device having multiple electrode/sensor capability and stimulation based on sensed intrinsic activity |
| US7672728B2 (en) * | 2005-12-28 | 2010-03-02 | Cardiac Pacemakers, Inc. | Neural stimulator to treat sleep disordered breathing |
| US7912537B2 (en) * | 2006-04-27 | 2011-03-22 | Medtronic, Inc. | Telemetry-synchronized physiological monitoring and therapy delivery systems |
| AU2012200979B2 (en) | 2006-08-25 | 2013-08-29 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
| US8103341B2 (en) | 2006-08-25 | 2012-01-24 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
| US8600505B2 (en) | 2011-12-07 | 2013-12-03 | Cyberonics, Inc. | Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction |
-
2006
- 2006-08-25 US US11/467,264 patent/US8103341B2/en not_active Expired - Fee Related
-
2007
- 2007-06-29 AU AU2007287006A patent/AU2007287006B2/en not_active Ceased
- 2007-06-29 EP EP15155658.6A patent/EP2902076A1/en not_active Withdrawn
- 2007-06-29 WO PCT/US2007/072444 patent/WO2008024557A1/en not_active Ceased
- 2007-06-29 EP EP07799163.6A patent/EP2077893B1/en not_active Not-in-force
- 2007-06-29 JP JP2009525669A patent/JP2010501269A/ja active Pending
- 2007-06-29 CN CN2007800315349A patent/CN101505827B/zh not_active Expired - Fee Related
- 2007-06-29 CN CN201310009045.0A patent/CN103083810B/zh not_active Expired - Fee Related
-
2012
- 2012-01-23 US US13/356,380 patent/US8527042B2/en active Active
-
2013
- 2013-08-28 US US14/012,036 patent/US8897881B2/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040193231A1 (en) * | 2001-08-31 | 2004-09-30 | Biocontrol Medical Ltd. | Selective nerve fiber stimulation for treating heart conditions |
| US20060190053A1 (en) * | 2002-03-22 | 2006-08-24 | Dobak John D Iii | Neural stimulation for treatment of metabolic syndrome and type 2 diabetes |
| US20060116737A1 (en) * | 2004-11-30 | 2006-06-01 | Cardiac Pacemakers, Inc. | Neural stimulation with avoidance of inappropriate stimulation |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8897881B2 (en) | 2006-08-25 | 2014-11-25 | Cardiac Pacemakers, Inc. | System for abating neural stimulation side effects |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2902076A1 (en) | 2015-08-05 |
| EP2077893A1 (en) | 2009-07-15 |
| CN103083810B (zh) | 2016-04-20 |
| CN101505827B (zh) | 2013-02-27 |
| CN103083810A (zh) | 2013-05-08 |
| CN101505827A (zh) | 2009-08-12 |
| US8103341B2 (en) | 2012-01-24 |
| AU2007287006A1 (en) | 2008-02-28 |
| EP2077893B1 (en) | 2015-07-22 |
| US8897881B2 (en) | 2014-11-25 |
| US20130345776A1 (en) | 2013-12-26 |
| JP2010501269A (ja) | 2010-01-21 |
| WO2008024557A1 (en) | 2008-02-28 |
| US8527042B2 (en) | 2013-09-03 |
| US20120123494A1 (en) | 2012-05-17 |
| US20080051839A1 (en) | 2008-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11446501B2 (en) | Systems and methods for delivering vagal nerve stimulation | |
| AU2007287006B2 (en) | System for abating neural stimulation side effects | |
| US8447394B2 (en) | Physical conditioning system, device and method | |
| US8630716B2 (en) | Systems and methods for providing neural stimulation transitions | |
| US8725247B2 (en) | Unidirectional neural stimulation systems, devices and methods | |
| AU2012200979B2 (en) | System for abating neural stimulation side effects | |
| AU2011250875A1 (en) | Unidirectional neural stimulation systems, devices and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |